International Business Machines Corporation

New York Stock Exchange
Slightly Bullish +25

INTERNATIONAL BUSINESS MACHINES ($IBM) Releases Q1 2026 Earnings - Quiver Quantitative

πŸ“… International Business Machines (IBM) released its Q1 2026 earnings report on Wednesday, April 22nd.

πŸ’° The company reported quarterly earnings of $1.91 per share, surpassing analyst estimates of $1.82 by $0.09.

πŸ“ˆ Total revenue came in at $15.917 billion, beating the consensus estimate of approximately $15.766 billion by about $151 million.

πŸ“‰ Despite strong earnings and revenue beats, the stock price fell 7.03% after market close on April 22nd.

🀡 Recent insider trading activity shows a net positive trend with three purchases and zero sales over the last six months.

🏒 Institutional investors have shifted positions slightly, with 1,629 adding shares while 1,494 decreased their holdings in the most recent quarter.

πŸ’Έ Award payments to IBM employees totaled $1.057 billion over the last year according to reported data.

βš–οΈ Congressional trading activity shows balanced interest with members making 8 purchases and 9 sales of IBM stock in the past six months.

πŸ“Š Wall Street sentiment remains largely bullish with five firms issuing buy ratings compared to just one firm issuing a sell rating.

🎯 Analyst price targets have been established by 12 analysts recently, setting a median target price of $320.0 per share.

Bullish Signals
  • INTERNATIONAL BUSINESS MACHINES beat earnings expectations with $1.91 per share, surpassing analyst estimates of $1.82 by $0.09, while also reporting revenue of $15.92 billion that exceeded projections by $151 million.
  • Insider sentiment remains bullish as trading history shows 3 purchases and 0 sales by company insiders in the last six months, indicating confidence from those closest to the business operations.
  • Strong institutional interest is evident with 1,629 institutional investors adding shares to their portfolios compared to only 1,494 decreasing positions during the most recent quarter.
  • Wall Street maintains a positive outlook with five firms issuing buy ratings on the stock versus just one firm issuing a sell rating in recent analyst reports.
  • Analysts have established a median price target of $320.0 for the stock based on forecasts from 12 different analysts over the last six months, suggesting significant upside potential.
Risk Factors
  • The stock price fell 7.03% after the earnings release, indicating negative market sentiment despite beating earnings expectations.
  • Institutional investors decreased their positions by 1,494 while only 1,629 added shares, resulting in a net reduction in institutional ownership.
  • Members of Congress sold $IBM stock 9 times in the past 6 months compared to only 8 purchases, showing mixed or slightly negative congressional sentiment.
  • Wall Street analysts issued one sell rating against five buy ratings, reflecting ongoing debate and potential concerns about the stock's valuation or prospects.
Full Analysis
International Business Machines (IBM) reported its first-quarter 2026 earnings results on Wednesday, April 22nd, delivering strong financial performance that exceeded Wall Street expectations. The company posted quarterly earnings of $1.91 per share, surpassing analyst estimates of $1.82 by a margin of $0.09. Revenue for the quarter reached $15,917,000,000, which beat the estimated figure of $15,765,533,460 by approximately $151 million. Despite these positive earnings and revenue figures, IBM's stock price declined by 7.03% following the market close on April 22nd. In terms of insider activity over the past six months, executives have demonstrated a bullish sentiment, having executed three trades that were exclusively purchases with no sales recorded during that period. Institutional investors showed mixed signals, with 1,629 firms adding shares to their portfolios while 1,494 decreased their positions in the most recent quarter. Additionally, approximately $1.057 billion in award payments were distributed to IBM employees over the last year. Congressional trading activity also took place, with members of Congress executing 17 trades in the past six months, split between 8 purchases and 9 sales. Wall Street sentiment regarding IBM remains cautiously positive among analysts, who have issued ratings and price targets in recent months. Five firms have issued buy ratings on the stock compared to only one firm issuing a sell rating. A total of 12 analysts have provided price targets for IBM over the last six months, establishing a median target price of $320.00 per share. While these metrics suggest fundamental strength and analyst confidence in the company's valuation, the immediate market reaction was negative with the stock dropping significantly after earnings release, likely influenced by broader market conditions or specific guidance not detailed in this report.